The latest closing stock price for Neumora Therapeutics as of January 21, 2025 is 2.06.
An investor who bought $1,000 worth of Neumora Therapeutics stock at the IPO in 2023 would have $-873 today, roughly -1 times their original investment - a -87.32% compound annual growth rate over 1 years.
The all-time high Neumora Therapeutics stock closing price was 19.76 on February 16, 2024.
The Neumora Therapeutics 52-week high stock price is 21.00, which is 919.4% above the current share price.
The Neumora Therapeutics 52-week low stock price is 1.83, which is 11.2% below the current share price.
The average Neumora Therapeutics stock price for the last 52 weeks is 11.83.
An investor who bought $1,000 worth of Neumora Therapeutics stock at the IPO in 2023 would have $-873 today, roughly -1 times their original investment - a -87.32% compound annual growth rate over 1 years.
The all-time high Neumora Therapeutics stock closing price was 19.76 on February 16, 2024.
The Neumora Therapeutics 52-week high stock price is 21.00, which is 919.4% above the current share price.
The Neumora Therapeutics 52-week low stock price is 1.83, which is 11.2% below the current share price.
The average Neumora Therapeutics stock price for the last 52 weeks is 11.83.